Cargando…
Thymidylate synthase polymorphism and survival of colorectal cancer patients treated with 5-fluorouracil
British Journal of Cancer (2002) 86, 1365. DOI: 10.1038/sj/bjc/6600229 www.bjcancer.com © 2002 Cancer Research UK
Autores principales: | Ulrich, C M, Potter, J D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375340/ https://www.ncbi.nlm.nih.gov/pubmed/11953901 http://dx.doi.org/10.1038/sj.bjc.6600229 |
Ejemplares similares
-
Reply: Thymidylate synthase polymorphism and survival of colorectal cancer patients treated with 5-fluorouracil
por: Iacopetta, B, et al.
Publicado: (2002) -
A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil
por: Iacopetta, B, et al.
Publicado: (2001) -
Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity
por: Etienne, M-C, et al.
Publicado: (2004) -
Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy
por: Graziano, F, et al.
Publicado: (2008) -
Is thymidylate synthase a reliable predictor for response and survival during hepatic arterial infusion for hepatic metastases from colorectal cancer?
por: Ferretti, G, et al.
Publicado: (2006)